Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron Dose-ranging for PONV Prevention
NCT02478645Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramosetron in postoperative nausea and vomiting (PONV), sponsored by Yonsei University. Started Jun 2015; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02478645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478645.